Sort
21,453 grants matching “tuberculosis”
Impact of SARS-CoV-2 infection on reactivation of latent Mtb infections in a Kenyan Cohort
$137,078Jesse Gitaka · Mount Kenya University · R01 · FY2023 · AI
Tuberculosis Transmission and Preventive Therapy in Tibetan Children and Young Adults in India
$137,001Kunchok Dorjee · Johns Hopkins University · K01 · FY2023 · AI
Flow Cytometry Core
$136,968Steven A Porcelli · Albert Einstein College Of Medicine · P01 · FY2012 · AI
Mycolate-specific T cell function in human immunity to Mycobacterium tuberculosis
$136,957Anne Kasmar · Brigham And Women'S Hospital · K08 · FY2010 · AI
Adaptation, fitness and resistance in rifampicin-resistant M. tuberculosis
$136,947Elizabeth Maria Streicher · Stellenbosch University · R01 · FY2023 · AI
Linkage & Retention: A Randomized Trial to Optimize HIV/TB Care in South Africa
$136,891Ingrid Valerie Bassett · Massachusetts General Hospital · R01 · FY2012 · MH
Structure, function, and regulation of the bacterial transcription cycle
$136,724Seth A Darst · Rockefeller University · R35 · FY2017 · GM
Novel DNA Manufacturing Process: Cell-Free Production and Testing of a New Multiv
$136,720Frederic Kendirgi · Cytogenix, Inc. · R43 · FY2008 · AI
Investigating the sequelae of pulmonary tuberculosis in Gambian children and adolescents
$136,718Esin Nkereuwem · Medical Research Council Unit The Gambia At The London School Of Hygiene & Tropical Medicine · K43 · FY2025 · TW
Mechanisms of cell growth arrest in latent tuberculosis.
$136,710Public Health Research Institute · K01 · FY2004 · HL
Mechanisms of cell growth arrest in latent tuberculosis.
$136,710Patricia A Fontan · Univ Of Med/Dent Of Nj-Nj Medical School · K01 · FY2008 · HL
Mechanisms of cell growth arrest in latent tuberculosis.
$136,710Public Health Research Institute · K01 · FY2005 · HL
Mechanisms of cell growth arrest in latent tuberculosis.
$136,710Patricia A Fontan · Univ Of Med/Dent Of Nj-Nj Medical School · K01 · FY2007 · HL
The Public Health Impact of ART in South Africa
$136,670Mark Nathan Lurie · Brown University · K01 · FY2007 · MH
Teens on TB Treatment: Predicting Adherence through Clinical Decision Analysis
$136,623Silvia Shinpei Chiang · Rhode Island Hospital · K01 · FY2020 · TW
PROCESS DEVELOPMENT OF TELACEBEC FOR TUBERCULOSIS
$136,605Desmond Slade · Midwest Research Institute · N01 · FY2025 · DA
INFECTIOUS DISEASES CORE
$136,566David C Perlman · New York University · P30 · FY2009 · DA
TUBERCULOSIS ELIMINATION AND LABORATORY
$136,520Susan Schoenfeld · Vermont State Department Of Health · U52 · FY2008 · PS
TUBERCULOSIS ELIMINATION AND LABORATORY
$136,520Susan Schoenfeld · Vermont State Department Of Health · U52 · FY2009 · PS
Impact of antiretrovial therapy on liver fibrosis in Zambian HIV/HBV patients
$136,474Michael Jeffrey Vinikoor · University Of Alabama At Birmingham · K01 · FY2016 · TW
eMicrobes: A Digital Library for Learning Infectious Diseases
$136,406Rajesh T Gandhi · Massachusetts General Hospital · G08 · FY2009 · LM
eMicrobes: A Digital Library for Learning Infectious Diseases
$136,402Rajesh T Gandhi · Massachusetts General Hospital · G08 · FY2008 · LM
Immunological significance of QuantiFERON TB Gold In-tube reversions in settings with high burden of tuberculosis
$136,383Elisa Nemes · University Of Cape Town · R21 · FY2016 · AI
Effect of HIV Infection on Pulmonary MDR-TB Transmission and Virulence
$136,350Ashwin S. Dharmadhikari · Brigham And Women'S Hospital · K23 · FY2013 · AI
Effect of HIV Infection on Pulmonary MDR-TB Transmission and Virulence
$136,350Ashwin S. Dharmadhikari · Brigham And Women'S Hospital · K23 · FY2011 · AI